Jeffrey N. Simmons - 19 Feb 2025 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role
PRESIDENT, CEO AND DIRECTOR, Director
Signature
/s/ Amy C. Seidel, as Attorney-in-Fact for Jeffrey N. Simmons
Issuer symbol
ELAN
Transactions as of
19 Feb 2025
Net transactions value
-$2,201,242
Form type
4
Filing time
21 Feb 2025, 18:15:15 UTC
Previous filing
11 Feb 2025
Next filing
25 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELAN Common Stock Award $0 +449,408 +33% $0.000000 1,808,688 19 Feb 2025 Direct F1, F2
transaction ELAN Common Stock Tax liability $2,201,242 -195,840 -11% $11.24 1,612,848 19 Feb 2025 Direct
holding ELAN Common Stock 145,000 19 Feb 2025 By Revocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Corrects the number of shares purchased under Elanco Animal Health Inc.'s Employee Stock Purchase Plan on December 30, 2022, June 30, 2023 and April 30, 2024 by deducting 825 shares.
F2 Includes 1,751 shares acquired on January 31, 2025 under Elanco Animal Health Inc.'s Employee Stock Purchase Plan.